Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial.

Stacey BR, Dworkin RH, Murphy K, Sharma U, Emir B, Griesing T.

Pain Med. 2008 Nov;9(8):1202-8. doi: 10.1111/j.1526-4637.2008.00423.x. Epub 2008 Mar 11.

PMID:
18346060
2.

Pharmacologic management of neuropathic pain: evidence-based recommendations.

Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS.

Pain. 2007 Dec 5;132(3):237-51. Epub 2007 Oct 24. Review.

PMID:
17920770
3.

Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.

Tölle T, Freynhagen R, Versavel M, Trostmann U, Young JP Jr.

Eur J Pain. 2008 Feb;12(2):203-13. Epub 2007 Jul 16.

PMID:
17631400
4.

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, Raskin J.

Neurology. 2006 Oct 24;67(8):1411-20.

PMID:
17060567
5.

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ; CONSORT Group..

JAMA. 2006 Mar 8;295(10):1152-60. Erratum in: JAMA. 2006 Oct 18;296(15):1842.

PMID:
16522836
6.

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.

Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF.

Pain Med. 2005 Sep-Oct;6(5):346-56.

PMID:
16266355
7.

Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep.

Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B.

J Pain Symptom Manage. 2005 Oct;30(4):374-85.

PMID:
16256902
8.

Duloxetine vs. placebo in patients with painful diabetic neuropathy.

Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S.

Pain. 2005 Jul;116(1-2):109-18.

PMID:
15927394
9.
10.

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.

Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE.

J Pain. 2005 Apr;6(4):253-60.

PMID:
15820913
11.

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.

Lesser H, Sharma U, LaMoreaux L, Poole RM.

Neurology. 2004 Dec 14;63(11):2104-10.

PMID:
15596757
12.

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.

Rosenstock J, Tuchman M, LaMoreaux L, Sharma U.

Pain. 2004 Aug;110(3):628-38.

PMID:
15288403
13.

Cyclic antidepressants and the risk of sudden cardiac death.

Ray WA, Meredith S, Thapa PB, Hall K, Murray KT.

Clin Pharmacol Ther. 2004 Mar;75(3):234-41.

PMID:
15001975
14.

Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.

Backonja M, Glanzman RL.

Clin Ther. 2003 Jan;25(1):81-104. Review.

PMID:
12637113
15.

Sociological influences on antidepressant prescribing.

Sleath B, Shih YC.

Soc Sci Med. 2003 Mar;56(6):1335-44.

PMID:
12600369
16.
17.

Descending modulation in persistent pain: an update.

Ren K, Dubner R.

Pain. 2002 Nov;100(1-2):1-6. Review. No abstract available.

PMID:
12435453
18.

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.

Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, Hemrick-Luecke SK, Wong DT.

Neuropsychopharmacology. 2001 Dec;25(6):871-80.

19.
20.

Diabetic neuropathy: pathogenesis and therapy.

Vinik AI.

Am J Med. 1999 Aug 30;107(2B):17S-26S. Review.

PMID:
10484041

Supplemental Content

Support Center